Stromacel IncOver The Counter Market:PROT
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Stromacel Inc | 10.0 | 0.0x | --- |
MetaStat Inc | 590.0 | 0.0x | --- |
Cell Kinetics Ltd | 2.0K | 0.0x | --- |
BioSyntech Inc | 120.0 | 0.0x | --- |
Nanobac Pharmaceuticals Inc | 250.0 | 0.0x | --- |
HempAmericana Inc | 2.9K | 0.0x | --- |
Company Information
Stromacel Inc. is a biotechnology company. The Company is a subsidiary of Proteonomix Inc. It offers technology in the field of cellular medicine to international clients. The Company intends to conduct phased human studies of its cellular materials in application to the treatment of cardiac and other diseases.
Contact Information
- Headquarters
- 187 Mill LnMOUNTAINSIDE, NJ, United States 07092-2918
- Phone
- 973-544-6116
- Fax
- 302-531-3150
Executives
- Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer
- Michael Cohen
- Chief Financial Officer
- Thomas Monahan
- Chief Technical Officer, Director
- Steven Byle
- Vice President - Scientific Development , Chief Scientific Officer, Director
- Ian Mcniece
- General Counsel, Treasurer, Director
- Roger Fidler
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.00 |
|---|---|
Revenue (TTM) | $26.0K |
Shares Outstanding | 7.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.10 |
Book Value | $-0.48 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -14,546.69% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
